Employees Provident Fund Board’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6M Buy
90,000
+36,108
+67% +$12.4M 0.19% 53
2026
Q1
$19M Sell
53,892
-24,608
-31% -$8.77M 0.14% 59
2025
Q4
$25.7M Sell
78,500
-2,500
-3% -$793K 0.19% 53
2025
Q3
$22.9M Buy
81,000
+2,093
+3% +$607K 0.18% 55
2025
Q2
$22M Buy
78,907
+28,707
+57% +$8.13M 0.19% 64
2025
Q1
$15.6M Sell
50,200
-6,800
-12% -$2.01M 0.18% 71
2024
Q4
$14.9M Buy
57,000
+15,400
+37% +$4.57M 0.18% 64
2024
Q3
$13.4M Sell
41,600
-200
-0.5% -$65.4K 0.18% 69
2024
Q2
$13.1M Sell
41,800
-6,200
-13% -$1.82M 0.21% 64
2024
Q1
$13.6M Sell
48,000
-2,000
-4% -$585K 0.24% 60
2023
Q4
$14.4M Buy
50,000
+4,000
+9% +$1.09M 0.28% 51
2023
Q3
$12.4M Sell
46,000
-6,500
-12% -$1.62M 0.28% 57
2023
Q2
$11.7M Buy
52,500
+19,400
+59% +$4.5M 0.28% 55
2023
Q1
$8M Buy
+33,100
New +$8.13M 0.21% 58
2020
Q2
Sell
-39,898
Closed -$8.09M 66
2020
Q1
$8.09M Buy
+39,898
New +$8.71M 0.22% 55
2016
Q1
Sell
-1,307,342
Closed -$34.8M 37
2015
Q4
$34.8M Buy
1,307,342
+1,180,007
+927% +$185M 1.19% 27
2015
Q3
$17.6M Sell
127,335
-49,688
-28% -$7.83M 0.67% 36
2015
Q2
$27.2M Buy
177,023
+72,850
+70% +$11.7M 0.95% 34
2015
Q1
$16.7M Buy
+104,173
New +$16.4M 0.57% 42
2014
Q2
Sell
-184,705
Closed -$22M 56
2014
Q1
$22M Hold
184,705
0.71% 39
2013
Q4
$21.1M Buy
+184,705
New +$21M 0.64% 39

Other funds holding AMGN

Employees Provident Fund Board's AMGN Position: Q2 2026 in Review

Employees Provident Fund Board increased its Amgen (AMGN) stake by 67% in Q2 2026, buying an estimated $12.4M and bringing the position to 90,000 shares worth $32.6M. The position accounts for 0.19% of the portfolio, ranked #53.

Employees Provident Fund Board first reported a position in AMGN in Q4 2013 and has held it in 21 quarters since. The position peaked at $34.8M in Q4 2015. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Employees Provident Fund Board held 90,000 shares of Amgen worth $32.6M as of Q2 2026.
  • Employees Provident Fund Board bought 36,108 Amgen shares in Q2 2026, an estimated $12.4M.
  • Amgen made up 0.19% of Employees Provident Fund Board's portfolio in Q2 2026, its #53 holding.
  • Employees Provident Fund Board first reported a position in Amgen in Q4 2013 and has held it in 21 quarters since.
  • Employees Provident Fund Board's Amgen position peaked at $34.8M in Q4 2015.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.